LIVANOVA PLC (LIVN) Stock Fundamental Analysis

NASDAQ:LIVN • GB00BYMT0J19

70.29 USD
+1.24 (+1.8%)
At close: Feb 25, 2026
70.29 USD
0 (0%)
After Hours: 2/25/2026, 5:47:43 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

Taking everything into account, LIVN scores 5 out of 10 in our fundamental rating. LIVN was compared to 185 industry peers in the Health Care Equipment & Supplies industry. LIVN has an average financial health and profitability rating. LIVN has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • LIVN had positive earnings in the past year.
  • LIVN had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: LIVN reported negative net income in multiple years.
  • Of the past 5 years LIVN 4 years had a positive operating cash flow.
LIVN Yearly Net Income VS EBIT VS OCF VS FCFLIVN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

  • LIVN has a Return On Assets of -8.50%. This is in the better half of the industry: LIVN outperforms 63.78% of its industry peers.
  • Looking at the Return On Equity, with a value of -18.78%, LIVN is in the better half of the industry, outperforming 61.08% of the companies in the same industry.
  • LIVN has a Return On Invested Capital of 8.35%. This is amongst the best in the industry. LIVN outperforms 84.86% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for LIVN is significantly below the industry average of 8.75%.
  • The 3 year average ROIC (3.45%) for LIVN is below the current ROIC(8.35%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -8.5%
ROE -18.78%
ROIC 8.35%
ROA(3y)-0.17%
ROA(5y)-4.24%
ROE(3y)-0.33%
ROE(5y)-8.58%
ROIC(3y)3.45%
ROIC(5y)N/A
LIVN Yearly ROA, ROE, ROICLIVN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

  • LIVN has a Operating Margin of 14.94%. This is amongst the best in the industry. LIVN outperforms 82.70% of its industry peers.
  • LIVN's Operating Margin has improved in the last couple of years.
  • LIVN has a better Gross Margin (68.50%) than 75.14% of its industry peers.
  • LIVN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 14.94%
PM (TTM) N/A
GM 68.5%
OM growth 3Y41.76%
OM growth 5Y18.95%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.63%
GM growth 5Y0.8%
LIVN Yearly Profit, Operating, Gross MarginsLIVN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • LIVN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • LIVN has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for LIVN has been increased compared to 5 years ago.
  • Compared to 1 year ago, LIVN has a worse debt to assets ratio.
LIVN Yearly Shares OutstandingLIVN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
LIVN Yearly Total Debt VS Total AssetsLIVN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • An Altman-Z score of 1.89 indicates that LIVN is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • The Altman-Z score of LIVN (1.89) is comparable to the rest of the industry.
  • LIVN has a debt to FCF ratio of 2.26. This is a good value and a sign of high solvency as LIVN would need 2.26 years to pay back of all of its debts.
  • LIVN has a better Debt to FCF ratio (2.26) than 85.95% of its industry peers.
  • LIVN has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.30, LIVN is in line with its industry, outperforming 51.89% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 2.26
Altman-Z 1.89
ROIC/WACC0.96
WACC8.68%
LIVN Yearly LT Debt VS Equity VS FCFLIVN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 1.33 indicates that LIVN should not have too much problems paying its short term obligations.
  • LIVN has a worse Current ratio (1.33) than 78.38% of its industry peers.
  • LIVN has a Quick Ratio of 1.12. This is a normal value and indicates that LIVN is financially healthy and should not expect problems in meeting its short term obligations.
  • LIVN's Quick ratio of 1.12 is on the low side compared to the rest of the industry. LIVN is outperformed by 73.51% of its industry peers.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 1.12
LIVN Yearly Current Assets VS Current LiabilitesLIVN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • LIVN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.24%, which is quite good.
  • Measured over the past 5 years, LIVN shows a small growth in Earnings Per Share. The EPS has been growing by 1.82% on average per year.
  • LIVN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.63%.
  • The Revenue has been growing slightly by 2.94% on average over the past years.
EPS 1Y (TTM)12.24%
EPS 3Y16.71%
EPS 5Y1.82%
EPS Q2Q%23.33%
Revenue 1Y (TTM)8.63%
Revenue growth 3Y6.58%
Revenue growth 5Y2.94%
Sales Q2Q%12.48%

3.2 Future

  • Based on estimates for the next years, LIVN will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.20% on average per year.
  • The Revenue is expected to grow by 6.85% on average over the next years.
EPS Next Y16.86%
EPS Next 2Y11.85%
EPS Next 3Y10.47%
EPS Next 5Y13.2%
Revenue Next Year10.7%
Revenue Next 2Y8.67%
Revenue Next 3Y7.95%
Revenue Next 5Y6.85%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
LIVN Yearly Revenue VS EstimatesLIVN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
LIVN Yearly EPS VS EstimatesLIVN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 18.26, which indicates a rather expensive current valuation of LIVN.
  • Compared to the rest of the industry, the Price/Earnings ratio of LIVN indicates a rather cheap valuation: LIVN is cheaper than 85.95% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.05, LIVN is valued a bit cheaper.
  • LIVN is valuated correctly with a Price/Forward Earnings ratio of 16.67.
  • Based on the Price/Forward Earnings ratio, LIVN is valued cheaply inside the industry as 87.03% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of LIVN to the average of the S&P500 Index (28.03), we can say LIVN is valued slightly cheaper.
Industry RankSector Rank
PE 18.26
Fwd PE 16.67
LIVN Price Earnings VS Forward Price EarningsLIVN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, LIVN is valued cheaper than 82.70% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, LIVN is valued cheaply inside the industry as 91.35% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 19.98
EV/EBITDA 14.47
LIVN Per share dataLIVN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • LIVN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • LIVN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.08
PEG (5Y)10.05
EPS Next 2Y11.85%
EPS Next 3Y10.47%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for LIVN!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

LIVANOVA PLC

NASDAQ:LIVN (2/25/2026, 5:47:43 PM)

After market: 70.29 0 (0%)

70.29

+1.24 (+1.8%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-05
Earnings (Next)02-25
Inst Owners105.72%
Inst Owner Change-2.18%
Ins Owners0.28%
Ins Owner Change0.34%
Market Cap3.84B
Revenue(TTM)1.35B
Net Income(TTM)-217.38M
Analysts82.35
Price Target73.19 (4.13%)
Short Float %4.48%
Short Ratio4.12
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.36%
Min EPS beat(2)18.42%
Max EPS beat(2)20.31%
EPS beat(4)3
Avg EPS beat(4)12.75%
Min EPS beat(4)-0.89%
Max EPS beat(4)20.31%
EPS beat(8)7
Avg EPS beat(8)18.55%
EPS beat(12)11
Avg EPS beat(12)18.19%
EPS beat(16)14
Avg EPS beat(16)14.3%
Revenue beat(2)2
Avg Revenue beat(2)3.07%
Min Revenue beat(2)2.12%
Max Revenue beat(2)4.01%
Revenue beat(4)3
Avg Revenue beat(4)1.56%
Min Revenue beat(4)-2.64%
Max Revenue beat(4)4.01%
Revenue beat(8)7
Avg Revenue beat(8)2.79%
Revenue beat(12)11
Avg Revenue beat(12)3.51%
Revenue beat(16)13
Avg Revenue beat(16)2.69%
PT rev (1m)0.25%
PT rev (3m)6.1%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.38%
EPS NY rev (1m)0%
EPS NY rev (3m)2.96%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.02%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.96%
Valuation
Industry RankSector Rank
PE 18.26
Fwd PE 16.67
P/S 2.85
P/FCF 19.98
P/OCF 15.3
P/B 3.32
P/tB 29.15
EV/EBITDA 14.47
EPS(TTM)3.85
EY5.48%
EPS(NY)4.22
Fwd EY6%
FCF(TTM)3.52
FCFY5.01%
OCF(TTM)4.6
OCFY6.54%
SpS24.7
BVpS21.19
TBVpS2.41
PEG (NY)1.08
PEG (5Y)10.05
Graham Number42.84
Profitability
Industry RankSector Rank
ROA -8.5%
ROE -18.78%
ROCE 11.65%
ROIC 8.35%
ROICexc 13.32%
ROICexgc 247.44%
OM 14.94%
PM (TTM) N/A
GM 68.5%
FCFM 14.24%
ROA(3y)-0.17%
ROA(5y)-4.24%
ROE(3y)-0.33%
ROE(5y)-8.58%
ROIC(3y)3.45%
ROIC(5y)N/A
ROICexc(3y)4.13%
ROICexc(5y)N/A
ROICexgc(3y)10.29%
ROICexgc(5y)N/A
ROCE(3y)4.82%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y4.42%
ROICexc growth 3Y38.42%
ROICexc growth 5Y24.6%
OM growth 3Y41.76%
OM growth 5Y18.95%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.63%
GM growth 5Y0.8%
F-Score6
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 2.26
Debt/EBITDA 1.42
Cap/Depr 132.33%
Cap/Sales 4.36%
Interest Coverage 250
Cash Conversion 102%
Profit Quality N/A
Current Ratio 1.33
Quick Ratio 1.12
Altman-Z 1.89
F-Score6
WACC8.68%
ROIC/WACC0.96
Cap/Depr(3y)78.91%
Cap/Depr(5y)67.73%
Cap/Sales(3y)3.13%
Cap/Sales(5y)3.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.24%
EPS 3Y16.71%
EPS 5Y1.82%
EPS Q2Q%23.33%
EPS Next Y16.86%
EPS Next 2Y11.85%
EPS Next 3Y10.47%
EPS Next 5Y13.2%
Revenue 1Y (TTM)8.63%
Revenue growth 3Y6.58%
Revenue growth 5Y2.94%
Sales Q2Q%12.48%
Revenue Next Year10.7%
Revenue Next 2Y8.67%
Revenue Next 3Y7.95%
Revenue Next 5Y6.85%
EBIT growth 1Y50.76%
EBIT growth 3Y51.09%
EBIT growth 5Y22.46%
EBIT Next Year41.25%
EBIT Next 3Y18.09%
EBIT Next 5Y3.36%
FCF growth 1Y2170.19%
FCF growth 3Y20.82%
FCF growth 5YN/A
OCF growth 1Y532.75%
OCF growth 3Y21.3%
OCF growth 5YN/A

LIVANOVA PLC / LIVN FAQ

Can you provide the ChartMill fundamental rating for LIVANOVA PLC?

ChartMill assigns a fundamental rating of 5 / 10 to LIVN.


Can you provide the valuation status for LIVANOVA PLC?

ChartMill assigns a valuation rating of 6 / 10 to LIVANOVA PLC (LIVN). This can be considered as Fairly Valued.


What is the profitability of LIVN stock?

LIVANOVA PLC (LIVN) has a profitability rating of 6 / 10.


What is the financial health of LIVANOVA PLC (LIVN) stock?

The financial health rating of LIVANOVA PLC (LIVN) is 4 / 10.


Can you provide the expected EPS growth for LIVN stock?

The Earnings per Share (EPS) of LIVANOVA PLC (LIVN) is expected to grow by 16.86% in the next year.